Distrac SA
12.9 FTEDistrac reported total assets of €6.86m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026), with 12.9 full-time equivalents.
The score of Distrac shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets -5 % Headcount (avg FTE) -17 %
Accounts of the company itself (not consolidated).
The full file covers 14 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Distrac's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 04 Jun 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 04 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Distrac's financial analysis
- Solvency52.8%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Distrac
Distrac's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0448.825.928
- VAT number
- BE0448825928
- Peppol
- Registered · 0208:0448825928 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Dec 1992
- Registered office
- 3320 Hoegaarden
- Size
- Small · 12.9 FTE
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Distrac (SA) has been based in Hoegaarden since 1992, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 197,879 € and equity of €3.62m; its revenue is not published. With 12.9 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 52.8%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Distrac
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- BD Infection Prevention Wholesale of pharmaceutical and medical goods Aalst · balance sheet €6.90m
- Ultimedi Wholesale of pharmaceutical and medical goods Wingene · balance sheet €6.99m
Frequently asked questions about Distrac
What is the revenue of Distrac?
Distrac files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Distrac?
In Belgium, the VAT number is the company number prefixed with BE: BE0448825928 for Distrac, if the company is VAT-registered. Its company number (CBE) is 0448.825.928.
Where is the registered office of Distrac?
According to the CBE register, the registered office of Distrac is in 3320 Hoegaarden.
What is the equity of Distrac?
At the close of the 2025 financial year, the equity of Distrac amounts to 3,617,940 €, a solvency of 52.8% of total assets.
How many people work at Distrac?
12.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Distrac?
The register lists 5 active mandates at Distrac. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Distrac
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →